Zacks Research Upgrades Humana (NYSE:HUM) to “Strong-Buy”

Humana (NYSE:HUM) was upgraded by research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Monday,Zacks.com reports.

HUM has been the subject of a number of other research reports. Royal Bank Of Canada boosted their price target on shares of Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 9th. Wells Fargo & Company raised shares of Humana from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $227.00 to $502.00 in a report on Monday. Wolfe Research upgraded shares of Humana from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. Piper Sandler reissued a “neutral” rating and issued a $254.00 target price (up from $182.00) on shares of Humana in a research note on Wednesday, May 13th. Finally, UBS Group reaffirmed a “neutral” rating on shares of Humana in a research note on Monday, June 15th. Two analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, fifteen have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $325.87.

Humana Stock Performance

NYSE:HUM opened at $406.70 on Monday. The stock has a market cap of $48.83 billion, a P/E ratio of 43.50, a PEG ratio of 2.31 and a beta of 0.71. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The business’s 50-day moving average price is $345.52 and its two-hundred day moving average price is $257.26. Humana has a twelve month low of $163.11 and a twelve month high of $415.00.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.Humana’s revenue was up 23.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities analysts predict that Humana will post 9.03 EPS for the current fiscal year.

Hedge Funds Weigh In On Humana

Large investors have recently added to or reduced their stakes in the business. Montag A & Associates Inc. boosted its position in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC lifted its stake in shares of Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana in the 4th quarter valued at about $27,000. Reflection Asset Management purchased a new stake in Humana during the 4th quarter valued at about $29,000. Finally, Rosenberg Matthew Hamilton boosted its holdings in Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.